Free Trial

Stevanato Group (NYSE:STVN) Stock Price Down 0.4% - Here's Why

Stevanato Group logo with Medical background

Stevanato Group S.p.A. (NYSE:STVN - Get Free Report)'s stock price was down 0.4% during trading on Wednesday . The company traded as low as €17.98 ($19.13) and last traded at €18.07 ($19.22). Approximately 68,949 shares were traded during trading, a decline of 87% from the average daily volume of 511,718 shares. The stock had previously closed at €18.15 ($19.31).

Analyst Ratings Changes

Separately, Citigroup lowered their price objective on Stevanato Group from $30.00 to $28.00 and set a "buy" rating on the stock in a research report on Wednesday, August 7th.

Check Out Our Latest Research Report on Stevanato Group

Stevanato Group Stock Up 0.4 %

The company's 50 day simple moving average is €19.46 and its 200-day simple moving average is €19.82. The firm has a market cap of $5.39 billion, a P/E ratio of 38.36, a PEG ratio of 8.55 and a beta of 0.58. The company has a current ratio of 1.81, a quick ratio of 1.21 and a debt-to-equity ratio of 0.22.

Stevanato Group (NYSE:STVN - Get Free Report) last posted its earnings results on Tuesday, November 5th. The company reported €0.12 ($0.13) EPS for the quarter, missing analysts' consensus estimates of €0.13 ($0.14) by (€0.01) (($0.01)). The company had revenue of €277.90 million during the quarter, compared to the consensus estimate of €274.36 million. Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. The company's revenue for the quarter was up 2.4% on a year-over-year basis. During the same period last year, the firm posted $0.16 EPS. Research analysts forecast that Stevanato Group S.p.A. will post 0.5 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Stevanato Group

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Tri Locum Partners LP bought a new position in shares of Stevanato Group during the 2nd quarter valued at approximately $10,370,000. Thrivent Financial for Lutherans bought a new stake in shares of Stevanato Group during the 2nd quarter valued at $30,477,000. Thornburg Investment Management Inc. lifted its stake in shares of Stevanato Group by 279.1% during the 2nd quarter. Thornburg Investment Management Inc. now owns 746,218 shares of the company's stock valued at $13,690,000 after buying an additional 549,378 shares in the last quarter. Comgest Global Investors S.A.S. boosted its holdings in Stevanato Group by 56.8% in the 2nd quarter. Comgest Global Investors S.A.S. now owns 394,120 shares of the company's stock worth $7,228,000 after buying an additional 142,754 shares during the period. Finally, Raymond James Trust N.A. increased its stake in Stevanato Group by 18.7% in the 2nd quarter. Raymond James Trust N.A. now owns 10,239 shares of the company's stock worth $188,000 after buying an additional 1,613 shares in the last quarter.

Stevanato Group Company Profile

(Get Free Report)

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

→ I was wrong. Dead wrong. (From Porter & Company) (Ad)

Should you invest $1,000 in Stevanato Group right now?

Before you consider Stevanato Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stevanato Group wasn't on the list.

While Stevanato Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Former Trump Advisor: Expect REITs to Soar Under Trump’s Next Presidency
Super Micro’s Rebound: Can SMCI Stock Rally Another 100%?
Why Meta Is Still a Top Stock Pick for 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines